Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Helicobacter pylori eradication versus continuous pantoprazole infusion for prevention of rebleeding in bleeding peptic ulcer
IRCT201108073836N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pantoprazole in Peptic ulcer disease (PUD) and Helicobacter pylori infection (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Dec 2011; status: completed.
02
Drugs
pantoprazole
03
Conditions
Peptic ulcer disease (PUD)Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT201108073836N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108073836N2.